OPK-88001

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOPK-88001
Drug Alias NameOPKO-CURNAAntagoNATCUR-1916OPK-88001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type I alpha subunit blockers
TargetsSodium channel protein type I alpha subunit
Therapy Area/IndicationsMucopolysaccharidosis IRett SyndromeEpilepsies, Myoclonic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOpko Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesOpko Health Inc
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis IRett SyndromeEpilepsies, Myoclonic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A